UnitedHealth Group (UNH) to Release Earnings on Tuesday

Key Points

• UnitedHealth Group (UNH) is set to announce its Q3 2025 earnings on October 28th, with expectations of earnings of $2.87 per share and revenue of $113.19 billion.
• In its last quarterly earnings report, UnitedHealth missed earnings estimates, reporting $4.08 EPS against a consensus of $4.45, despite achieving a revenue increase of 12.9% year-over-year.
• The company recently declared a quarterly dividend of $2.21 per share, resulting in an annualized yield of 2.4%, with a payout ratio of 38.3%.

UnitedHealth Group (NYSE:UNH - Get Free Report) is projected to release its Q3 2025 results before the market opens on Tuesday, October 28th. Analysts expect UnitedHealth Group to post earnings of $2.87 per share and revenue of $113.1918 billion for the quarter. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS.Interested persons can check the company's upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Tuesday, October 28, 2025 at 8:00 AM ET.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the business posted $6.80 earnings per share. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. On average, analysts expect UnitedHealth Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

UnitedHealth Group Price Performance

UNH stock opened at $364.31 on Tuesday. The firm has a 50 day moving average of $331.62 and a 200-day moving average of $341.12. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market capitalization of $329.95 billion, a P/E ratio of 15.78, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group's payout ratio is presently 38.30%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Riggs Asset Managment Co. Inc. raised its holdings in UnitedHealth Group by 69.4% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 43 shares during the last quarter. Binnacle Investments Inc raised its holdings in UnitedHealth Group by 185.8% in the 2nd quarter. Binnacle Investments Inc now owns 383 shares of the healthcare conglomerate's stock worth $119,000 after purchasing an additional 249 shares in the last quarter. WFA of San Diego LLC bought a new position in UnitedHealth Group in the 2nd quarter worth $152,000. FJ Capital Management LLC bought a new position in UnitedHealth Group in the 2nd quarter worth $260,000. Finally, Darwin Wealth Management LLC bought a new position in UnitedHealth Group in the 2nd quarter worth $293,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on UNH. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Zacks Research upgraded shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research report on Monday, October 6th. Baird R W lowered shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Jefferies Financial Group boosted their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a "buy" rating in a report on Friday. Finally, Bank of America boosted their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a "neutral" rating in a report on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.